The G Protein-Coupled Receptor (GPR) 15 Counteracts Antibody-Mediated Skin Inflammation

The G protein-coupled receptor 15 (GPR15) has recently been highlighted as an important regulator of T cell trafficking into the gut under physiological and pathophysiological conditions. Additionally, circumstantial evidence has accumulated that GPR15 may also play a role in the regulation of chron...

Full description

Bibliographic Details
Main Authors: Lina Jegodzinski, Tanya Sezin, Karin Loser, Sadegh Mousavi, Detlef Zillikens, Christian D. Sadik
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-08-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fimmu.2020.01858/full
_version_ 1818387444777615360
author Lina Jegodzinski
Tanya Sezin
Karin Loser
Sadegh Mousavi
Detlef Zillikens
Detlef Zillikens
Christian D. Sadik
Christian D. Sadik
author_facet Lina Jegodzinski
Tanya Sezin
Karin Loser
Sadegh Mousavi
Detlef Zillikens
Detlef Zillikens
Christian D. Sadik
Christian D. Sadik
author_sort Lina Jegodzinski
collection DOAJ
description The G protein-coupled receptor 15 (GPR15) has recently been highlighted as an important regulator of T cell trafficking into the gut under physiological and pathophysiological conditions. Additionally, circumstantial evidence has accumulated that GPR15 may also play a role in the regulation of chronic inflammation. However, the (patho)physiological significance of GPR15 has, in general, remained rather enigmatic. In the present study, we have addressed the role of GPR15 in the effector phase of autoantibody-mediated skin inflammation, specifically in the antibody transfer mouse model of bullous pemphigoid-like epidermolysis bullosa acquisita (BP-like EBA). Subjecting Gpr15−/− mice to this model, we have uncovered that GPR15 counteracts skin inflammation. Thus, disease was markedly aggravated in Gpr15−/− mice, which was associated with an increased accumulation of γδ T cells in the dermis. Furthermore, GPR15L, the recently discovered cognate ligand of GPR15, was markedly upregulated in inflamed skin. Collectively, our results highlight GPR15 as counter-regulator of neutrophilic, antibody-mediated cutaneous inflammation. Enhancing the activity of GPR15 may therefore constitute a novel therapeutic principle in the treatment of pemphigoid diseases, such as BP-like EBA.
first_indexed 2024-12-14T04:10:03Z
format Article
id doaj.art-7363bb0489ac4a849f6aed995a6d622a
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-12-14T04:10:03Z
publishDate 2020-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-7363bb0489ac4a849f6aed995a6d622a2022-12-21T23:17:42ZengFrontiers Media S.A.Frontiers in Immunology1664-32242020-08-011110.3389/fimmu.2020.01858548203The G Protein-Coupled Receptor (GPR) 15 Counteracts Antibody-Mediated Skin InflammationLina Jegodzinski0Tanya Sezin1Karin Loser2Sadegh Mousavi3Detlef Zillikens4Detlef Zillikens5Christian D. Sadik6Christian D. Sadik7Department of Dermatology, Allergy, and Venereology, University of Lübeck, Lübeck, GermanyDepartment of Dermatology, Allergy, and Venereology, University of Lübeck, Lübeck, GermanyDepartment of Dermatology, University of Münster, Münster, GermanyDepartment of Dermatology, Allergy, and Venereology, University of Lübeck, Lübeck, GermanyDepartment of Dermatology, Allergy, and Venereology, University of Lübeck, Lübeck, GermanyCenter for Research on Inflammation of the Skin, University of Lübeck, Lübeck, GermanyDepartment of Dermatology, Allergy, and Venereology, University of Lübeck, Lübeck, GermanyCenter for Research on Inflammation of the Skin, University of Lübeck, Lübeck, GermanyThe G protein-coupled receptor 15 (GPR15) has recently been highlighted as an important regulator of T cell trafficking into the gut under physiological and pathophysiological conditions. Additionally, circumstantial evidence has accumulated that GPR15 may also play a role in the regulation of chronic inflammation. However, the (patho)physiological significance of GPR15 has, in general, remained rather enigmatic. In the present study, we have addressed the role of GPR15 in the effector phase of autoantibody-mediated skin inflammation, specifically in the antibody transfer mouse model of bullous pemphigoid-like epidermolysis bullosa acquisita (BP-like EBA). Subjecting Gpr15−/− mice to this model, we have uncovered that GPR15 counteracts skin inflammation. Thus, disease was markedly aggravated in Gpr15−/− mice, which was associated with an increased accumulation of γδ T cells in the dermis. Furthermore, GPR15L, the recently discovered cognate ligand of GPR15, was markedly upregulated in inflamed skin. Collectively, our results highlight GPR15 as counter-regulator of neutrophilic, antibody-mediated cutaneous inflammation. Enhancing the activity of GPR15 may therefore constitute a novel therapeutic principle in the treatment of pemphigoid diseases, such as BP-like EBA.https://www.frontiersin.org/article/10.3389/fimmu.2020.01858/fullGPR15pemphigoid diseaseepidermolysis bullosa acquisitaautoantibodiesskin inflammationGPR15L
spellingShingle Lina Jegodzinski
Tanya Sezin
Karin Loser
Sadegh Mousavi
Detlef Zillikens
Detlef Zillikens
Christian D. Sadik
Christian D. Sadik
The G Protein-Coupled Receptor (GPR) 15 Counteracts Antibody-Mediated Skin Inflammation
Frontiers in Immunology
GPR15
pemphigoid disease
epidermolysis bullosa acquisita
autoantibodies
skin inflammation
GPR15L
title The G Protein-Coupled Receptor (GPR) 15 Counteracts Antibody-Mediated Skin Inflammation
title_full The G Protein-Coupled Receptor (GPR) 15 Counteracts Antibody-Mediated Skin Inflammation
title_fullStr The G Protein-Coupled Receptor (GPR) 15 Counteracts Antibody-Mediated Skin Inflammation
title_full_unstemmed The G Protein-Coupled Receptor (GPR) 15 Counteracts Antibody-Mediated Skin Inflammation
title_short The G Protein-Coupled Receptor (GPR) 15 Counteracts Antibody-Mediated Skin Inflammation
title_sort g protein coupled receptor gpr 15 counteracts antibody mediated skin inflammation
topic GPR15
pemphigoid disease
epidermolysis bullosa acquisita
autoantibodies
skin inflammation
GPR15L
url https://www.frontiersin.org/article/10.3389/fimmu.2020.01858/full
work_keys_str_mv AT linajegodzinski thegproteincoupledreceptorgpr15counteractsantibodymediatedskininflammation
AT tanyasezin thegproteincoupledreceptorgpr15counteractsantibodymediatedskininflammation
AT karinloser thegproteincoupledreceptorgpr15counteractsantibodymediatedskininflammation
AT sadeghmousavi thegproteincoupledreceptorgpr15counteractsantibodymediatedskininflammation
AT detlefzillikens thegproteincoupledreceptorgpr15counteractsantibodymediatedskininflammation
AT detlefzillikens thegproteincoupledreceptorgpr15counteractsantibodymediatedskininflammation
AT christiandsadik thegproteincoupledreceptorgpr15counteractsantibodymediatedskininflammation
AT christiandsadik thegproteincoupledreceptorgpr15counteractsantibodymediatedskininflammation
AT linajegodzinski gproteincoupledreceptorgpr15counteractsantibodymediatedskininflammation
AT tanyasezin gproteincoupledreceptorgpr15counteractsantibodymediatedskininflammation
AT karinloser gproteincoupledreceptorgpr15counteractsantibodymediatedskininflammation
AT sadeghmousavi gproteincoupledreceptorgpr15counteractsantibodymediatedskininflammation
AT detlefzillikens gproteincoupledreceptorgpr15counteractsantibodymediatedskininflammation
AT detlefzillikens gproteincoupledreceptorgpr15counteractsantibodymediatedskininflammation
AT christiandsadik gproteincoupledreceptorgpr15counteractsantibodymediatedskininflammation
AT christiandsadik gproteincoupledreceptorgpr15counteractsantibodymediatedskininflammation